FOSTIMON 150 IU Price

Overview

Welcome to Dwaey, specifically on FOSTIMON 150 IU Injection/Powder for page.
This medicine contains an important and useful components, as it consists of Urofollitropin (FSH).
FOSTIMON 150 IU is available in the market in concentration 150 IU/Vial and in the form of Injection/Powder for.

IBSA INSTITUT BIOCHIMIQUE S.A. is the producer of FOSTIMON 150 IU and it is imported from SWITZERLAND, The most popular alternatives of FOSTIMON 150 IU are listed downward .

Mode Of Action

Urofollitropin, a gonadotrophin obtained from postmenopausal women's urine, possesses follicle-stimulating hormone (FSH) activity but almost no luteinising activity. Admin for 7-12 days results in follicular growth and maturation in females. When sufficient follicular maturation has occurred, human chorionic gonadotrophin should be given to induce ovulation.

Indication

• Female infertility
• Hypogonadotrophic hypogonadism

Precaution

May result in multiple pregnancies. Abnormal genital bleeding, hormone sensitive malignancies, ovarian cysts not caused by polycystic ovary syndrome. Exclude and treat other causes of infertility e.g. pituitary or hypothalamic lesions, adrenal or thyroid disorders and hyperprolactinaemia.

Side Effects

• >10% Headache (11.1%)
• OHSS (11.1%; severe pelvic pain
• N/V
• weight gain) Frequency Not Defined Nausea
• vomiting
• joint pain
• ovarian hyperstimulation syndrome
• adnexal torsion
• mild to moderate ovarian enlargement
• abdominal pain
• ovarian cysts
• local reaction at inj site
• headaches
• haemoperitoneum
• benign and malignant ovarian neoplasms
• ascites
• pleural effusion
• hypovolaemia
• thromboembolic disorders. Weight gain
• acne and gynaecomastia in men. Potentially Fatal: Ovarian cysts rupture
• intraperitoneal haemorrhage.

Contra indication

Pregnancy, ovarian cysts or enlargement not due to polycystic ovary syndrome, primary ovarian failure, organic intracranial lesion e.g. pituitary tumour, uncontrolled thyroid and adrenal dysfunction, presence of any cause of infertility other than anovulation, abnormal bleeding of undetermined origin.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.